126 - NDA for ALKS5461; clearance for cobas® CT/NG for cobas® 6800/8800 Systems; FDA cracks down on dietary supplements with caffeine
Archived series ("Inactive feed" status)
When? This feed was archived on October 07, 2018 00:40 (). Last successful fetch was on August 31, 2018 22:03 ()
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 203397704 series 1587676
April 16, 2018
Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com
1:26 Alkermes announces FDA acceptance for review of New Drug Application for ALKS5461 for the adjunctive treatment of major depressive disorder https://www.prnewswire.com/news-releases/alkermes-announces-fda-acceptance-for-review-of-new-drug-application-for-alks-5461-for-the-adjunctive-treatment-of-major-depressive-disorder-300630031.html
3:20 Roche receives FDA clearance for cobas® CT/NG for cobas® 6800/8800 Systems https://www.prnewswire.com/news-releases/roche-receives-fda-clearance-for-cobas-ctng-for-cobas-68008800-systems-300629816.html
5:23 FDA takes step to protect consumers against dietary supplements containing dangerously high levels of extremely concentrated or pure caffeine https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm604485.htm
Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com.
Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
100 episodes